Type | Private |
---|---|
Industry | Healthcare |
Founded | 2007 |
Headquarters | Seattle, Washington, U.S. |
Key people | Kathleen Fondren (Chief Executive Officer), David J. Corwin, M.D. (President, CellNetix Pathology & Laboratories), David Kiehn (SVP/Chief Financial Officer) |
Services | Anatomic Pathology |
Number of employees | 300+ |
Website | www |
CellNetix Pathology & Laboratories, LLC, headquartered in Seattle, Washington, is a premier anatomic pathology provider in the Pacific Northwest, with 50 physicians and more than 300 total staff. Services include cytology, histology, fine needle aspiration (FNA) services, flow cytometry, immunohistochemistry, immunofluorescence, UroVysion™, and molecular diagnostics.
CellNetix institutes pollution prevention planning [1] and receives technical assistance from Washington State Department of Ecology.
CellNetix uses a subspecialized case allocation process [2] in which specimens arrive in the pathology laboratory and staff allocate them by subspecialty: breast cases to breast pathologists, gastroenterology (GI) cases to GI pathologists, genitourinary cases (GU) cases to GU pathologists, etc. In a typical case allocation process in a non-specialized pathology practice, cases are manually allocated to pathologists based on workload, without regard to the type of case. Tests are interpreted by board-certified pathologists who have experience in breast core biopsies, GI biopsies, Pap tests, and prostate biopsies.[ citation needed ]
CellNetix is expanding the utilization of molecular biology to identify the root cause of abnormalities within the genetic material of the cell itself. The CellNetix molecular pathology department tests for breast, gastric, colon and lung cancers, as well as melanoma. A women's health subspecialty provides high-risk HPV testing, testing for the detection of Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT), as well as vaginosis/vaginitis testing. [3]
CellNetix uses a specimen tracking system in which each specimen is labeled with a bar code and scanned up to 15 times during transit—from pickup at the hospital or clinic, to arrival at the lab, to final report. [4]
Early in 2012, the company invested in whole-slide imaging which views a live capture of the slide on a microscope. This is done using an ultra-high resolution scanner to image the complete slides and store them digitally. [5]
CellNetix spent 6 months validating WSI for use in diagnostic processes. It is now in daily use for digital IHC reads by pathologists at remote locations. They are also using WSI for HER2/neu diagnosis after a lengthy validation (comparing diagnosis by glass slide vs. digital image) for many cases by different pathologists. [5]
CellNetix is a physician- and employee-owned partnership formed in 2005 by the merger of three independent pathology groups—Black Hills Pathology (Olympia), Associated Pathology (Everett) and Washington Pathology Consultants (Seattle), with the addition of Northwest Pathology Group in 2008.[ citation needed ]
In 2007, CellNetix opened a 48,000-square-foot pathology and laboratory facility in downtown Seattle, where most of the testing is conducted. CellNetix provides diagnostic services for nine hospitals across western Washington as well as physicians and patients in Washington and Alaska. [6]
On December 4, 2012, Spokane, Wash.-based PAML (Pathology Associates Medical Laboratories) and CellNetix signed a letter of intent in which PAML agreed to purchase a minority ownership interest in CellNetix, LLC. As part of this partnership, CellNetix and PAML will form a jointly owned molecular pathology esoteric testing division. PAML employs approximately 1,400 staff and is 75% owned by Providence Health & Services and 25% by CHI (Catholic Health Initiative). By agreement, PAML and CellNetix will have a seat on each other's boards.[ citation needed ]
On May 2, 2013, PAML and CellNetix announced that PAML had completed a minority investment in the technical laboratory business division owned by CellNetix. The two companies also stated that they entered into an agreement to work together to form a “jointly owned national Esoteric Anatomic Pathology reference laboratory offering.” [7]
On February 28, 2017, just a week after Laboratory Corp. of America Holdings announced its plan to buy PAML, CellNetix bought back the 22% minority share from PAML to regain complete ownership. With this transaction, CellNetix Pathology and Laboratories became one of the largest independent, pathologist-owned groups in the country. [8]
Pathology is the study of the causes and effects of disease or injury. The word pathology also refers to the study of disease in general, incorporating a wide range of biology research fields and medical practices. However, when used in the context of modern medical treatment, the term is often used in a narrower fashion to refer to processes and tests which fall within the contemporary medical field of "general pathology", an area which includes a number of distinct but inter-related medical specialties that diagnose disease, mostly through analysis of tissue, cell, and body fluid samples. Idiomatically, "a pathology" may also refer to the predicted or actual progression of particular diseases, and the affix pathy is sometimes used to indicate a state of disease in cases of both physical ailment and psychological conditions. A physician practicing pathology is called a pathologist.
Anatomical pathology (Commonwealth) or Anatomic pathology (U.S.) is a medical specialty that is concerned with the diagnosis of disease based on the macroscopic, microscopic, biochemical, immunologic and molecular examination of organs and tissues. Over the last century, surgical pathology has evolved tremendously: from historical examination of whole bodies (autopsy) to a more modernized practice, centered on the diagnosis and prognosis of cancer to guide treatment decision-making in oncology. Its modern founder was the Italian scientist Giovan Battista Morgagni from Forlì.
Cytopathology is a branch of pathology that studies and diagnoses diseases on the cellular level. The discipline was founded by George Nicolas Papanicolaou in 1928. Cytopathology is generally used on samples of free cells or tissue fragments, in contrast to histopathology, which studies whole tissues. Cytopathology is frequently, less precisely, called "cytology", which means "the study of cells".
A biopsy is a medical test commonly performed by a surgeon, interventional radiologist, or an interventional cardiologist. The process involves extraction of sample cells or tissues for examination to determine the presence or extent of a disease. The tissue is generally examined under a microscope by a pathologist; it may also be analyzed chemically. When an entire lump or suspicious area is removed, the procedure is called an excisional biopsy. An incisional biopsy or core biopsy samples a portion of the abnormal tissue without attempting to remove the entire lesion or tumor. When a sample of tissue or fluid is removed with a needle in such a way that cells are removed without preserving the histological architecture of the tissue cells, the procedure is called a needle aspiration biopsy. Biopsies are most commonly performed for insight into possible cancerous or inflammatory conditions.
Histopathology refers to the microscopic examination of tissue in order to study the manifestations of disease. Specifically, in clinical medicine, histopathology refers to the examination of a biopsy or surgical specimen by a pathologist, after the specimen has been processed and histological sections have been placed onto glass slides. In contrast, cytopathology examines free cells or tissue micro-fragments.
Dermatopathology is a joint subspecialty of dermatology and pathology or surgical pathology that focuses on the study of cutaneous diseases at a microscopic and molecular level. It also encompasses analyses of the potential causes of skin diseases at a basic level. Dermatopathologists work in close association with clinical dermatologists, with many possessing further clinical training in dermatology.
Clinical pathology is a medical specialty that is concerned with the diagnosis of disease based on the laboratory analysis of bodily fluids, such as blood, urine, and tissue homogenates or extracts using the tools of chemistry, microbiology, hematology and molecular pathology. This specialty requires a medical residency.
The Armed Forces Institute of Pathology (AFIP) was a U.S. government institution concerned with diagnostic consultation, education, and research in the medical specialty of pathology.
Surgical pathology is the most significant and time-consuming area of practice for most anatomical pathologists. Surgical pathology involves gross and microscopic examination of surgical specimens, as well as biopsies submitted by surgeons and non-surgeons such as general internists, medical subspecialists, dermatologists, and interventional radiologists.
Renal pathology is a subspecialty of anatomic pathology that deals with the diagnosis and characterization of medical diseases (non-tumor) of the kidneys. In the academic setting, renal pathologists work closely with nephrologists and transplant surgeons, who typically obtain diagnostic specimens via percutaneous renal biopsy. The renal pathologist must synthesize findings from light microscopy, electron microscopy, and immunofluorescence to obtain a definitive diagnosis. Medical renal diseases may affect the glomerulus, the tubules and interstitium, the vessels, or a combination of these compartments.
Gastrointestinal pathology is the subspecialty of surgical pathology which deals with the diagnosis and characterization of neoplastic and non-neoplastic diseases of the digestive tract and accessory organs, such as the pancreas and liver.
[[
Skin biopsy is a biopsy technique in which a skin lesion is removed to be sent to a pathologist to render a microscopic diagnosis. It is usually done under local anesthetic in a physician's office, and results are often available in 4 to 10 days. It is commonly performed by dermatologists. Skin biopsies are also done by family physicians, internists, surgeons, and other specialties. However, performed incorrectly, and without appropriate clinical information, a pathologist's interpretation of a skin biopsy can be severely limited, and therefore doctors and patients may forgo traditional biopsy techniques and instead choose Mohs surgery. There are four main types of skin biopsies: shave biopsy, punch biopsy, excisional biopsy, and incisional biopsy. The choice of the different skin biopsies is dependent on the suspected diagnosis of the skin lesion. Like most biopsies, patient consent and anesthesia are prerequisites.
Digital pathology is a sub-field of pathology that focuses on data management based on information generated from digitized specimen slides. Through the use of computer-based technology, digital pathology utilizes virtual microscopy. Glass slides are converted into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. With the practice of Whole-Slide Imaging (WSI), which is another name for virtual microscopy, the field of digital pathology is growing and has applications in diagnostic medicine, with the goal of achieving efficient and cheaper diagnoses, prognosis, and prediction of diseases due to the success in Artificial Intelligence and Machine Learning.
Sunquest Information Systems Inc. is a U.S. developer of medical laboratory and diagnostic information solutions, with a user base of more than 1,700 hospitals and commercial laboratories. It was founded in 1979.
Juan Rosai was an Italian-born American physician who contributed to clinical research and education in the specialty of surgical pathology. He was the principal author and editor of a major textbook in that field, and he characterized novel medical conditions such as Rosai-Dorfman disease and the desmoplastic small round cell tumor. Rosai is also well-known because of his role as teacher, mentor and consultant to many American and international surgical pathologists.
Telepathology is the practice of pathology at a distance. It uses telecommunications technology to facilitate the transfer of image-rich pathology data between distant locations for the purposes of diagnosis, education, and research. Performance of telepathology requires that a pathologist selects the video images for analysis and the rendering of diagnoses. The use of "television microscopy", the forerunner of telepathology, did not require that a pathologist have physical or virtual "hands-on" involvement in the selection of microscopic fields-of-view for analysis and diagnosis.
American Pathology Partners, Inc. is a privately held medical laboratory company headquartered in Nashville, Tennessee. The company operates a nationwide network of pathology laboratories focused on local and regional healthcare. APP serves physician offices, hospitals, and surgery centers with sub-specialized anatomic and molecular pathology services including surgical pathology, cytopathology, dermatopathology, hematopathology, urologic pathology, gastrointestinal and liver pathology, renal pathology, and pediatric and perinatal pathology. APP currently operates laboratory facilities in Denver, Colorado; Wilson, North Carolina; and West Palm Beach, Florida doing business as UniPath, Eastern Carolina Pathology, and Palm Beach Pathology in their respective geographies.
Specimen provenance complications (SPCs) result from instances of biopsy specimen transposition, extraneous/foreign cell contamination or misidentification of cells used in clinical or anatomical pathology. If left undetected, SPCs can lead to serious diagnostic mistakes and adverse patient outcomes.
DNA Specimen Provenance Assignment (DSPA) also known as DNA Specimen ProvenanceAssay, is a molecular diagnostic test used to definitively assign biopsy specimen identity and establish specimen purity during the diagnostic testing cycle for cancer and other histopathological conditions. The term first appeared in the 2011 scientific paper, “The Changing Spectrum of DNA-Based Specimen Provenance Testing in Surgical Pathology,” published in the American Journal of Clinical Pathology, which built upon concepts described in an earlier paper published in the Journal of Urology.